Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years-old ...

Mirum Pharmaceuticals’ Ctexli (chenodiol) has gained US Food and Drug Administration (FDA) approval for treating adults with ...

The global biliary stent market was valued at approximately USD 394.5 million in 2022 and is projected to grow at a healthy CAGR of over 5.5% during the forecast period from 2023 ...

Sian Ashcroft, a 35-year-old mother of three, died just 18 days after being diagnosed with terminal cholangiocarcinoma in ...

The federal government has partnered the Israeli government towards enhancing access to complex surgeries of the pancreas, liver and the bile duct in the country.The Special Adviser to the President ...

Gilead Sciences, Inc. has received conditional marketing authorization from the European Commission (EC) for Seladelpar for the treatment of primary biliary cholangitis (PBC) ...

Daniel Bisogno, a renowned TV Azteca personality and co-host of the popular entertainment news program Ventaneando, has ...

Chenodiol -- a naturally occurring human bile acid also known as chenodeoxycholic acid -- is the first FDA-approved drug indicated for the rare lipid storage disease and autosomal recessive genetic ...

The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...

After losing her mother to gastrointestinal cancer, Sarah Wheeler rode for nine months, talking to people she met along the ...